Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model

Keyphrases

• Adaptive NK Cells 100%
• Interleukin-2 100%
• Anti-PD-1 Antibody 100%
• Cancer Model 100%
• NK Cell Therapy 100%
• Gastric Cancer 100%
• Activated NK Cells 100%
• Natural Killer Cells 80%
• Xenograft 60%
• Anti-programmed Cell Death Protein 1 (anti-PD-1) 60%
• Tumor Growth Inhibition 40%
• Gastric Tumor 40%
• Tumor 20%
• Tumor Model 20%
• Monotherapy 20%
• Feeder 20%
• Nivolumab 20%
• Immunohistochemistry 20%
• Cytotoxicity 20%
• Infiltration 20%
• Adoptive Transfer 20%
• Mouse Tumor Model 20%
• Flow Cytometry 20%
• Cytotoxic Effect 20%
• Cytotoxic Activity 20%
• Lactate Dehydrogenase 20%
• Pathological Response 20%
• Tumor Volume 20%
• Promising Treatment 20%
• Checkpoint Molecules 20%
• Gastric Cancer Cell Lines 20%
• Combined Method 20%
• Morphometric Traits 20%
• Polytherapy 20%
• Mitotic Count 20%
• NK Cell Proliferation 20%
• MKN-45 Cells 20%
• Lactate Dehydrogenase Assay 20%
• Tumor-infiltrating Immune Cells 20%
• Anti-PD-1 Therapy 20%
• Immune Checkpoint Inhibitors 20%
• Inhibitor Molecules 20%
• Tumor-infiltrating NK Cells 20%

Immunology and Microbiology

• Natural Killer Cell 100%
• Interleukin 2 38%
• Xenograft 23%
• Cytotoxicity 15%
• Growth Inhibition 15%
• Lactic Acid 15%
• Lactate 15%
• Immune Cell Infiltration 7%
• Mouse Model 7%
• Cell Proliferation 7%
• Staining 7%
• Nivolumab 7%
• Tumor Volume 7%
• Gastric Cancer Cell Line 7%
• Immunotherapy 7%
• Epstein Barr Virus 7%
• Immune Checkpoint Inhibitor 7%